Screener
Werewolf Therapeutics, Inc. HOWL Q4 2025 Annual earnings
Reported March 27, 2026 · Before market open
EPS-$0.20Beat by $0.14
Revenue estimate$300.0K
EPS estimate-$0.34
Next report
Nov 3, 2026 (in 3 months)Revenue estimate$18.3M
EPS estimate-$0.22
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Werewolf Therapeutics, Inc. report Q4 2025 earnings?
- Werewolf Therapeutics, Inc. (HOWL) reported Q4 2025 earnings on March 27, 2026 before market open.
- What were Werewolf Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Werewolf Therapeutics, Inc. reported eps of $-0.20 for Q4 2025.
- Did Werewolf Therapeutics, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.34 by $0.14.
- How did Werewolf Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 56.5% from $-0.46.
- Where can I find Werewolf Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001785530-26-000005) and the 10-K periodic report (0001785530-26-000006) directly on SEC EDGAR. The filing index links above go to sec.gov.
